You might like
Petition: RELEASE OF HOSTAGES HELD BY HAMAS lp.bringthemhomenow.net/petition
Kremlin adviser says he 'cannot comprehend' Ukraine invasion mol.im/a/10569613 via @MailOnline
dailymail.co.uk
Kremlin adviser says he 'cannot comprehend' Ukraine invasion
Andrey Kortunov said 'many of us are depressed' in an extraordinary intervention, after Vladimir Putin made his country a pariah on the international stage.
Are you a conservative who praised Putin, but now need to hate him? Ask your doctor about Tyranol.
How can anyone with any understanding of the world call Putin’s decision to invade Ukraine “genius” and “very savvy” as we watch him unite the rest of the world against Russia in nearly an instant?
Effective immediately, the Government of Canada announced its intention to ban all Russian-owned or registered ships and fishing vessels from entering Canadian ports and internal waters. ow.ly/Xk8j30sccYy
* RUSSIAN MOVE ON KYIV IS STALLED, OFFICIAL SAYS * U.S. HAS INDICATIONS THAT SOME RUSSIAN UNITS HAVE SURRENDERED WITHOUT A FIGHT, U.S. OFFICIAL SAYS @Reuters
Stratus Reimagines MLS wavgroup.com/2021/09/30/str…
wavgroup.com
Stratus Reimagines MLS
Stratus may have sparked some innovation here in America; we have always thought of the MLS as an agent-centric ecosystem. Sure, there are client servicing tools, but they are limited to buying and...
On October 6th we're hosting the next #MarketInsightForum focused on innovation in real estate. Carlos Grass (@grassc) will join as a panelist to talk about the role blockchain plays in the advancement of the end-to-end real estate process. Register today: bit.ly/3jS8klu
$AMRN Jefferies University: AMRN – Patent Lawyer Conf. Call to Discuss Vascepa Litigation Decision centurylink.cwebcast.com/ses/1rvwqrkLXy…~~?ek=f4f15723-f85d-4e26-b828-ada777e21139
Somebody decided to invite Dr. Rishi Desai onto Fox. I don’t think they’ll be asking him back.
I wonder if $AMRN started trials with Vascepa and prove useful in treating lung inflammation in Covid-19 patients
VASCEPA has been assessed by independent bodies as priced cost effectively as a cardiovascular risk reduction treatment VASCEPA total net revenue guidance increased for 2019 to a range of $410 to $425 million and for 2020 is newly guided to a projected range of $650 to $700M
Cardiovascular disease events, including heart attack, stroke and cardiovascular death, occur in the United States every 14 seconds and are economically, physically and emotionally costly
VASCEPA becomes the first and only FDA-approved medication for reducing cardiovascular risk beyond cholesterol lowering therapy in high-risk patients approved for treatment Millions of people in the United States qualify as treatment candidates for VASCEPA
FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups fda.gov/news-events/pr…
$AMRN - Just in case some of you missed this interview bloomberg.com/news/videos/20…
$AMRN files app for IP on statin combo. Is Combo priced in? Nope PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND DERIVATIVES THEREOF AND A STATIN dropbox.com/s/uwb9k6ofegrq…
dropbox.com
US20190099422A1.pdf
Shared with Dropbox
United States Trends
- 1. #GMMTV2026 1.08M posts
- 2. MILKLOVE BORN TO SHINE 197K posts
- 3. Good Tuesday 22.4K posts
- 4. WILLIAMEST MAGIC VIBES 25.3K posts
- 5. TOP CALL 9,348 posts
- 6. #WWERaw 78.3K posts
- 7. AI Alert 8,142 posts
- 8. Barcelona 147K posts
- 9. Moe Odum N/A
- 10. Brock 42.2K posts
- 11. Purdy 28.6K posts
- 12. Alan Dershowitz 2,842 posts
- 13. Check Analyze 2,425 posts
- 14. Bryce 21.4K posts
- 15. Token Signal 8,615 posts
- 16. Keegan Murray 1,563 posts
- 17. Dialyn 8,065 posts
- 18. Market Focus 4,669 posts
- 19. Timberwolves 3,942 posts
- 20. Finch 15K posts
Something went wrong.
Something went wrong.